By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...
The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.
Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...
Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...
A federal court in Pennsylvania granted final approval of a $200 million class-action settlement resolving antitrust claims that generic drug manufacturers conspired to inflate prices. The agreement ...
We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...
The Food and Drug Administration on Monday announced it had approved generic versions of Vyvanse, an increasingly popular alternative to Adderall. Commonly prescribed ...
The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...
Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...
The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results